Compare
Enlivex Ltd. vs Core Scientific, Inc./tx vs Chime Financial, Inc. vs Yiren Digital Ltd.
| Latest fiscal year | Enlivex Ltd. ENLV | Core Scientific, Inc./tx CORZ | Chime Financial, Inc. CHYM | Yiren Digital Ltd. YRD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $319.02M | $2.19B | $817.84M |
| Revenue growth (YoY) | n/a | -37.5% | +30.7% | n/a |
| Gross margin | n/a | 11.9% | 88.0% | n/a |
| Operating margin | n/a | -77.0% | -47.6% | -103.9% |
| Net margin | n/a | -90.5% | -46.2% | 1.0% |
| Net income | $1.24B | -$288.62M | -$1.01B | $7.80M |
| EPS (Diluted) | $25.48 | -$0.88 | -$4.27 | $0.0446 |
| Operating cash flow | -$10.42M | $278.25M | $52.78M | $100.62M |
| Free cash flow | -$10.48M | -$450.75M | $32.89M | $96.94M |
| Cash & equivalents | $1.89M | $311.38M | $466.25M | $478.78M |
| Total assets | $2.33B | $2.35B | $1.96B | $1.92B |
| Total liabilities | $392.05M | $3.31B | $562.90M | $598.15M |
| Shareholders' equity | $1.93B | -$962.74M | $1.40B | $1.33B |
| Return on year-end equity | 63.9% | n/a | -72.1% | 0.6% |
| Shares outstanding | 237.38M | 314.23M | n/a | 174.68M |
Revenue, most recent five fiscal years
| Fiscal year | Enlivex Ltd. | Core Scientific, Inc./tx | Chime Financial, Inc. | Yiren Digital Ltd. |
|---|---|---|---|---|
| Latest | n/a | $319.02M Ended 2025-12-31 | $2.19B Ended 2025-12-31 | $817.84M Ended 2025-12-31 |
| 1 year earlier | n/a | $510.67M Ended 2024-12-31 | $1.67B Ended 2024-12-31 | n/a |
| 2 years earlier | n/a | $502.40M Ended 2023-12-31 | $1.28B Ended 2023-12-31 | n/a |
| 3 years earlier | n/a | $640.31M Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $544.48M Ended 2021-12-31 | n/a | n/a |